/DH
DH Stock - Definitive Healthcare Corp.
Healthcare|Medical - Healthcare Information ServicesNASDAQ
$2.54-1.55%
$0.04 (-1.55%) • Dec 19
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.10
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).96
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.56
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+23.2%upside
Target: $3.13
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for DH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.51 – $2.57
TARGET (TP)$3.13
STOP LOSS$2.34
RISK/REWARD1:2.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.61
52W High$5.68
52W Low$2.15
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $252.20M | $251.41M | $222.65M | $166.15M | $118.32M |
| Gross Profit | $197.47M | $203.93M | $180.03M | $125.47M | $87.85M |
| Gross Margin | 78.3% | 81.1% | 80.9% | 75.5% | 74.2% |
| Operating Income | $-710,820,000 | $-329,800,000 | $-44,043,000 | $-27,317,000 | $-15,886,000 |
| Net Income | $-413,124,000 | $-202,388,000 | $-7,222,000 | $-51,908,000 | $-52,598,000 |
| Net Margin | -163.8% | -80.5% | -3.2% | -31.2% | -44.5% |
| EPS | $-3.54 | $-1.79 | $-0.07 | $-0.19 | $-0.53 |
Company Overview
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
30%
Hold / Neutral
7
70%
Sell / Underperform
0%
Analyst Consensus🔴 Bearish
3 Bullish7 Neutral/Bearish
Price Targets
$11
Average Target
↑ 323.2% Upside
Now
$4
Low
$11
Average
$30
High
Based on 8 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| May 9th 2025 | BTIG Research | Downgrade | Neutral | - |
| January 13th 2025 | Barclays | Downgrade | Underweight | $4 |
| December 20th 2024 | Stephens | Initiation | Equal Weight | $5 |
| September 17th 2024 | BTIG Research | Initiation | Buy | $7 |
| July 31st 2024 | JP Morgan | Downgrade | Underweight | $5← $7 |
| May 8th 2024 | Morgan Stanley | Downgrade | Equal Weight | $9← $11.5 |
| January 17th 2024 | Needham | Downgrade | Hold | - |
| January 5th 2024 | Canaccord Genuity | Downgrade | Hold | - |
| July 24th 2023 | Robert W. Baird | Downgrade | Neutral | $13 |
| April 19th 2023 | William Blair | Initiation | Outperform | - |
| December 9th 2022 | BofA Securities | Initiation | Neutral | $13 |
| July 6th 2022 | Needham | Initiation | Buy | $30 |
Earnings History & Surprises
DHBeat Rate
71%
Last 17 quarters
Avg Surprise
+27.9%
EPS vs Estimate
Beats / Misses
12/2
3 met exactly
Latest EPS
$0.07
Q4 2025
EPS Surprise History
Q1 24
0.0%
$0.07vs$0.07
Q2 24
0.0%
$0.08vs$0.08
Q3 24
0.0%
$0.09vs$0.09
Q4 24
+25.0%
$0.10vs$0.08
Q1 25
+14.3%
$0.08vs$0.07
Q2 25
+150.0%
$0.05vs$0.02
Q3 25
+40.0%
$0.07vs$0.05
Q4 25
+16.7%
$0.07vs$0.06
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $0.06 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.06 | $0.07 | +16.7% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.05 | $0.07 | +40.0% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $0.02 | $0.05 | +150.0% | ✓ BEAT |
Q1 2025 | Feb 27, 2025 | $0.07 | $0.08 | +14.3% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $0.08 | $0.10 | +25.0% | ✓ BEAT |
Q3 2024 | Aug 5, 2024 | $0.09 | $0.09 | 0.0% | = MET |
Q2 2024 | May 7, 2024 | $0.08 | $0.08 | 0.0% | = MET |
Q1 2024 | Feb 28, 2024 | $0.07 | $0.07 | 0.0% | = MET |
Q4 2023 | Nov 2, 2023 | $0.06 | $0.09 | +50.0% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $0.05 | $0.08 | +60.0% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.05 | $0.06 | +20.0% | ✓ BEAT |
Q1 2023 | Feb 23, 2023 | $0.04 | $0.07 | +67.7% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $0.05 | $0.06 | +20.0% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $0.05 | $0.06 | +20.0% | ✓ BEAT |
Q2 2022 | May 5, 2022 | $0.03 | $0.05 | +44.9% | ✓ BEAT |
Q1 2022 | Feb 23, 2022 | $0.04 | $0.04 | -7.4% | ✗ MISS |
Q4 2021 | Nov 8, 2021 | $0.02 | $0.01 | -47.4% | ✗ MISS |
Q3 2021 | Sep 16, 2021 | — | $-0.12 | — | — |
Latest News
Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $2.75
📉 NegativeBenzinga•Dec 9, 2025, 04:33 PM•Also:
Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $4
➖ NeutralBenzinga•Nov 10, 2025, 08:27 PM•Also:
Definitive Healthcare Raises FY2025 Adj EPS Guidance from $0.22-$0.23 to $0.23-$0.24 vs $0.23 Est; Raises FY2025 Sales Guidance from $237.000M-$240.000M to $239.000M-$240.000M vs $238.424M Est
📈 PositiveBenzinga•Nov 6, 2025, 09:16 PM
Definitive Healthcare Sees Q4 Adj EPS $0.05-$0.06 vs $0.06 Est; Sees Sales $59.000M-$60.000M vs $59.148M Est
📉 NegativeBenzinga•Nov 6, 2025, 09:15 PM
Definitive Healthcare Q3 Adj. EPS $0.07 Beats $0.06 Estimate, Sales $60.046M Beat $59.488M Estimate
📈 PositiveBenzinga•Nov 6, 2025, 09:07 PM
Frequently Asked Questions about DH
What is DH's current stock price?
Definitive Healthcare Corp. (DH) is currently trading at $2.54 per share. The stock has moved -1.55% today.
What is the analyst price target for DH?
The average analyst price target for DH is $3.13, based on 1 analyst.
What sector is Definitive Healthcare Corp. in?
Definitive Healthcare Corp. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.
What is DH's market cap?
Definitive Healthcare Corp. has a market capitalization of $0.26 billion, making it a small-cap company.
Does DH pay dividends?
No, Definitive Healthcare Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCABA
Cabaletta Bio, Inc.
$2.39
Mkt Cap: $0.2B
EDIT
Editas Medicine, Inc.
$2.34
Mkt Cap: $0.2B
KYTX
Kyverna Therapeutics, Inc.
$7.19
Mkt Cap: $0.3B
NAKA
Kindly MD, Inc.
$0.39
Mkt Cap: $0.1B
NRC
National Research Corporation
$18.70
Mkt Cap: $0.4B
OMI
Owens & Minor, Inc.
$2.84
Mkt Cap: $0.2B
SLP
Simulations Plus, Inc.
$18.75
Mkt Cap: $0.4B
SOPH
SOPHiA GENETICS S.A.
$4.61
Mkt Cap: $0.3B
SPOK
Spok Holdings, Inc.
$12.93
Mkt Cap: $0.3B
TBRG
TruBridge, Inc.
$22.36
Mkt Cap: $0.3B
Explore stocks similar to DH for comparison